
WindRose Health Investors
Description
WindRose Health Investors, LLC is a distinguished private equity firm based in New York, specializing exclusively in the healthcare services sector. Established in 1997, the firm boasts a long and successful track record of investing in businesses that provide critical services across the healthcare ecosystem. WindRose employs a flexible investment strategy, engaging in growth equity investments, recapitalizations, and buyouts, aiming to partner with companies demonstrating strong management teams and significant potential for expansion.
The firm's investment thesis centers on identifying companies with differentiated service offerings and robust growth prospects within various healthcare sub-sectors, including tech-enabled services, outsourced solutions, specialty distribution, and consumer-directed health. WindRose is known for its hands-on approach, working closely with portfolio company management to accelerate growth, optimize operations, and pursue strategic acquisitions. This collaborative model is a cornerstone of their value creation strategy, leveraging their deep industry expertise and extensive network.
WindRose Health Investors manages a substantial capital base, with over $2.0 billion in capital under management. Their commitment to the healthcare sector is underscored by their successful fundraising efforts, including the closing of WindRose Health Investors V, LP in 2020, which secured $717 million in commitments. The firm typically targets companies with enterprise values ranging from $50 million to $500 million, seeking to provide the necessary capital and strategic guidance to scale operations and enhance market leadership. Their investment philosophy emphasizes long-term partnerships and sustainable growth within the dynamic healthcare landscape.
Investor Profile
WindRose Health Investors has backed more than 27 startups, with 2 new investments in the last 12 months alone. The firm has led 19 rounds, about 70% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Israel.
- Strong thematic focus on Health Care, Medical, Biotechnology.
- Led 1 rounds in the past year.
- Typical check size: $25M – $150M.
Stage Focus
- Private Equity (78%)
- Series Unknown (7%)
- Series A (7%)
- Seed (4%)
- Secondary Market (4%)
Country Focus
- United States (93%)
- United Kingdom (4%)
- Israel (4%)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Hospital
- Fitness
- Consulting
- Information Technology
- Pharmaceutical
- Manufacturing
- Wellness
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.